- Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
- ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
- ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
- Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
- Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
- Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
More ▼
Key statistics
On Wednesday, Enzo Biochem Inc (ENZ:NYQ) closed at 1.07, 8.07% above its 52-week low of 0.9901, set on May 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.08 |
---|---|
High | 1.08 |
Low | 0.995 |
Bid | 0.9602 |
Offer | 1.50 |
Previous close | 1.07 |
Average volume | 191.34k |
---|---|
Shares outstanding | 51.46m |
Free float | 39.06m |
P/E (TTM) | -- |
Market cap | 55.06m USD |
EPS (TTM) | -0.3516 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 22:00 BST.
More ▼